Answer
Fenofibrate activates PPARα, increasing lipolysis and elimination of atherogenic triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing apoprotein C-III production.
Sources for this answer
- Lipantil Micro 67Viatris (formerly Mylan or Upjohn) · emc · SmPC §5.1 Pharmacodynamic properties · Version 30Document updated
Sources checked